These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 28142109)
21. Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. Lucchini E; Palandri F; Volpetti S; Vianelli N; Auteri G; Rossi E; Patriarca A; Carli G; Barcellini W; Celli M; Consoli U; Valeri F; Santoro C; Crea E; Vignetti M; Paoloni F; Gigliotti CL; Boggio E; Dianzani U; Giardini I; Carpenedo M; Rodeghiero F; Fanin R; Zaja F; Br J Haematol; 2021 Apr; 193(2):386-396. PubMed ID: 33618438 [TBL] [Abstract][Full Text] [Related]
22. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series. Kowalczyk M; Rubinstein PG; Aboulafia DM J Int Assoc Provid AIDS Care; 2015; 14(3):211-6. PubMed ID: 25504472 [TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia. Agnelli Giacchello J; Valeri F; Boccadoro M; Borchiellini A Eur J Haematol; 2018 Mar; 100(3):304-307. PubMed ID: 29243329 [TBL] [Abstract][Full Text] [Related]
24. Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia. Mingot-Castellano ME; Caparrós IS; Fernández F; Perera-Alvarez MDM; Jimenez-Bárcenas R; Casaus García A; González-Silva M; Yera-Cobo M; Nieto-Hernandez MM; Rodríguez-Fernandez MJ; Díaz-Canales D Blood Coagul Fibrinolysis; 2018 Jun; 29(4):374-380. PubMed ID: 29738335 [TBL] [Abstract][Full Text] [Related]
25. Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond. Taylor A; Westwood JP; Laskou F; McGuckin S; Scully M Br J Haematol; 2017 May; 177(3):475-480. PubMed ID: 28295201 [TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Makar RS; Zhukov OS; Sahud MA; Kuter DJ Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253 [TBL] [Abstract][Full Text] [Related]
27. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults. Červinek L; Mayer J; Doubek M Int J Hematol; 2015 Jul; 102(1):7-11. PubMed ID: 25833724 [TBL] [Abstract][Full Text] [Related]
28. Is ITP a thrombophilic disorder? Rodeghiero F Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507 [TBL] [Abstract][Full Text] [Related]
29. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. Bussel JB; Cheng G; Saleh MN; Psaila B; Kovaleva L; Meddeb B; Kloczko J; Hassani H; Mayer B; Stone NL; Arning M; Provan D; Jenkins JM N Engl J Med; 2007 Nov; 357(22):2237-47. PubMed ID: 18046028 [TBL] [Abstract][Full Text] [Related]
30. Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists. Garabet L; Ghanima W; Hellum M; Sandset PM; Bussel JB; Tran H; Henriksson CE Platelets; 2020; 31(3):322-328. PubMed ID: 31280643 [TBL] [Abstract][Full Text] [Related]
31. Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP. Zhu Y; Wang Y; Zhao Y; Liu D; Wang X; Zhu L; Tong J; Zhao N; Zheng C Ann Hematol; 2024 Aug; 103(8):2729-2741. PubMed ID: 38890176 [TBL] [Abstract][Full Text] [Related]
32. Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center. González KJ; Zuluaga SO; DaRos CV; Rodríguez PP; Martí AC Ann Hematol; 2017 Mar; 96(3):507-508. PubMed ID: 27975127 [No Abstract] [Full Text] [Related]
33. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Kühne T; Imbach P Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290 [TBL] [Abstract][Full Text] [Related]
34. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP]. Mori M; Kato M; Koh K; Hanada R Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675 [TBL] [Abstract][Full Text] [Related]
35. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. González-López TJ; Alvarez-Román MT; Pascual C; Sánchez-González B; Fernández-Fuentes F; Pérez-Rus G; Hernández-Rivas JA; Bernat S; Bastida JM; Martínez-Badas MP; Martínez-Robles V; Soto I; Olivera P; Bolaños E; Alonso R; Entrena L; Gómez-Nuñez M; Alonso A; Yera Cobo M; Caparrós I; Tenorio M; Arrieta-Cerdán E; Lopez-Ansoar E; García-Frade J; González-Porras JR Br J Haematol; 2017 Sep; 178(6):959-970. PubMed ID: 28573819 [TBL] [Abstract][Full Text] [Related]
36. TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP. Fujita S; Nakanishi T; Yoshimura H; Hotta M; Nakamichi N; Tamaki T; Ishii K; Ito T; Nomura S Thromb Res; 2012 Sep; 130(3):415-9. PubMed ID: 22789125 [TBL] [Abstract][Full Text] [Related]
37. Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ma D; Zhu X; Zhao P; Zhao C; Li X; Zhu Y; Li L; Sun J; Peng J; Ji C; Hou M Ann Hematol; 2008 Nov; 87(11):899-904. PubMed ID: 18600325 [TBL] [Abstract][Full Text] [Related]
38. Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura. Bal G; Fabian D; Maia D; Ringel F; Salama A Ann Hematol; 2017 Dec; 96(12):2045-2056. PubMed ID: 28965224 [TBL] [Abstract][Full Text] [Related]
39. Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel. Cooper N; Hill QA; Grainger J; Westwood JP; Bradbury C; Provan D; Thachil J; Ramscar N; Roy A Acta Haematol; 2021; 144(4):418-426. PubMed ID: 33789275 [TBL] [Abstract][Full Text] [Related]
40. Elevated Semaphorin 5A correlated with Th1 polarization in patients with chronic immune thrombocytopenia. Lyu M; Li Y; Hao Y; Sun T; Liu W; Lyu C; Fu R; Li H; Xue F; Liu X; Zhang L; Yang R Thromb Res; 2015 Nov; 136(5):859-64. PubMed ID: 26272304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]